{"status":"OK","msg":"Details loaded!","speaker":{"id":7,"speaker":"Graciela D\u00edaz de Delgado","sarx_lecture":"Use of the PDF-4\/Organics in the characterization of Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulations","sarx_lecture_abstract":"Characterization of Active Pharmaceutical Ingredients (APIs) and excipients, either as raw materials or in the finished product, is of importance in order to assess the quality of pharmaceutical products. Over the years we have studied a variety of antihistaminics, bronchodilators, anticonvulsives, antifungals, mineral supplements, among other compounds, which are part of commercial formulations available in the market. have also been studied. Some of these compounds have produced new polymorphs, new solvates, or new derivatives, upon recrystallization, heat treatment, grinding, reactions with metal salts, sometimes under relatively mild conditions.\r\n\r\nIn this presentation, examples of the use of ICDD's PDF-4\/Organics database will be presented to illustrate its capabilities in the characterization of pure APIs and excipients and of these materials in commercial formulations.","earj_lecture":"","earj_lecture_abstract":"","country":"Venezuela","institution":"University of the Andes (Venezuela)","earj":0,"sarx":1,"duration":30,"short_bio":null,"cvlink":"https:\/\/www.researchgate.net\/profile\/Graciela_Diaz_de_Delgado","picture":"http:\/\/sarx2016.nbcgib.uesc.br\/speaker\/7\/picture","email":"diaz@ula.ve","cvfile":null,"created_at":"-0001-11-30 00:00:00","updated_at":"2016-08-15 00:56:56","lecture":"Use of the PDF-4\/Organics in the characterization of Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulations","abstract":"Characterization of Active Pharmaceutical Ingredients (APIs) and excipients, either as raw materials or in the finished product, is of importance in order to assess the quality of pharmaceutical products. Over the years we have studied a variety of antihistaminics, bronchodilators, anticonvulsives, antifungals, mineral supplements, among other compounds, which are part of commercial formulations available in the market. have also been studied. Some of these compounds have produced new polymorphs, new solvates, or new derivatives, upon recrystallization, heat treatment, grinding, reactions with metal salts, sometimes under relatively mild conditions.
\r\n
\r\nIn this presentation, examples of the use of ICDD's PDF-4\/Organics database will be presented to illustrate its capabilities in the characterization of pure APIs and excipients and of these materials in commercial formulations."}}